INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 168 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $612,321 | -12.1% | 19,365 | +13.4% | 0.00% | -33.3% |
Q2 2023 | $696,400 | +39.2% | 17,077 | +27.2% | 0.00% | +50.0% |
Q1 2023 | $500,238 | +1.4% | 13,422 | -5.1% | 0.00% | 0.0% |
Q4 2022 | $493,240 | -38.1% | 14,137 | -0.7% | 0.00% | -60.0% |
Q3 2022 | $797,000 | +47.0% | 14,240 | +36.0% | 0.01% | +66.7% |
Q2 2022 | $542,000 | -40.9% | 10,470 | -17.0% | 0.00% | -50.0% |
Q1 2022 | $917,000 | -62.7% | 12,615 | -39.3% | 0.01% | -64.7% |
Q4 2021 | $2,456,000 | +6.8% | 20,770 | +21.1% | 0.02% | -10.5% |
Q3 2021 | $2,300,000 | -4.0% | 17,145 | +15.9% | 0.02% | -13.6% |
Q2 2021 | $2,395,000 | +95.8% | 14,794 | -2.9% | 0.02% | +69.2% |
Q1 2021 | $1,223,000 | +606.9% | 15,243 | +379.6% | 0.01% | +550.0% |
Q4 2020 | $173,000 | +1822.2% | 3,178 | +601.5% | 0.00% | – |
Q3 2020 | $9,000 | +800.0% | 453 | +754.7% | 0.00% | – |
Q2 2020 | $1,000 | -85.7% | 53 | -79.4% | 0.00% | – |
Q3 2018 | $7,000 | -30.0% | 257 | -31.5% | 0.00% | -100.0% |
Q2 2018 | $10,000 | – | 375 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 1,615,321 | $23,697,000 | 41.29% |
ARK Investment Management | 8,741,432 | $128,237,000 | 3.23% |
Nikko Asset Management Americas, Inc. | 7,178,520 | $105,309,000 | 1.66% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $1,635,000 | 0.86% |
Elmwood Wealth Management, Inc. | 64,204 | $942,000 | 0.82% |
361 CAPITAL LLC | 94,772 | $1,390,000 | 0.38% |
Artal Group S.A. | 199,700 | $2,930,000 | 0.11% |
StoneX Group Inc. | 14,982 | $220,000 | 0.09% |
Sumitomo Mitsui Trust Holdings, Inc. | 7,178,520 | $105,309,000 | 0.08% |
PDT Partners, LLC | 85,517 | $1,255,000 | 0.08% |